Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Mixed Analyst Opinions on Lemonade LMND Stock

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Finance_Fiscal (2)
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

As of March 4, 2024, analysts have differing opinions on Lemonade (LMND) stock. Thomas McJoynt-Griffith from Keefe, Bruyette & Woods has upgraded the price target from $16 to $18 while maintaining a Market Perform rating. The consensus among eight analysts is a price target of $17.75, with estimates ranging from $9.00 to higher values. Another source has reported that Keefe, Bruyette & Woods started coverage on Lemonade with a Market Perform rating and a $24 price target.

Lemonade Inc. (LMND) Shows Strong Performance in Stock Market on March 4, 2024

On March 4, 2024, Lemonade Inc. (LMND) showed strong performance in the stock market. LMND is currently trading in the middle of its 52-week range and above its 200-day simple moving average, indicating positive momentum for the stock. The price of LMND shares increased by $0.68 since the market last closed, representing a 4.19% rise from its previous closing price of $16.92. In pre-market trading on March 4, LMND continued to show strength, with the stock rising by an additional $0.09. Overall, the performance of LMND on March 4, 2024, is indicative of a strong and positive trend for the stock.

Lemonade Inc. (LMND) Stock Performance and Financial Results Analysis 2024

On March 4, 2024, Lemonade Inc. (LMND) stock performance was closely watched by investors and analysts as the company released its financial results for the past year and the fourth quarter. According to data from CNN Money, Lemonade reported a total revenue of $360.00 million for the past year, representing an impressive 86.92% increase from the previous year. However, the total revenue remained flat at $97.10 million for the fourth quarter compared to the previous quarter. Lemonade reported a net loss of -$236.90 million for the past year, which was an improvement of 20.45% compared to the previous year. In the fourth quarter, the net loss narrowed to -$42.40 million, showing a slight improvement from the previous quarter. The earnings per share (EPS) also showed positive growth, with an increase of 25.86% for the past year and remaining stable at -$0.61 for the fourth quarter. Overall, Lemonade’s financial performance for the past year and the fourth quarter demonstrated strong revenue growth and improvements in net income. Despite the net losses, the company’s EPS showed positive growth, indicating potential for future profitability. Investors and analysts will be closely monitoring Lemonade’s performance in the coming quarters to see if the company can sustain its growth trajectory and work towards achieving profitability.

Tags: LMND
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
CRWD stock news

Revolutionizing Web Design Wix Unveils AI Website Builder

Finance_ Stock Trading (2)

Anticipation for V2X Quarterly Earnings Report What Investors Need to Know

Finances

Anticipation Builds for Nuveis Quarterly Earnings Report

Recommended

Jakks Pacific Reports Disappointing Q4 2023 Earnings

2 years ago
Ecommerce Stock Exchange

Notable Options Market Activity for Shopify

2 years ago
Fannie Mae Stock

Fannie Mae’s Public Offering Plans Derailed by Prominent Investor

3 months ago
Ocugen Stock

Ocugen Shares Face Critical Test Amid Steep Decline

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Trending

Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

by Rodolfo Hanigan
February 7, 2026
0

Investors in Viking Therapeutics are currently focused on a specific calendar event rather than breaking news. The...

Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment
  • Diginex Enters Critical Implementation Phase Following Strategic Moves
  • Deluxe Stock Gains Momentum on Successful Fintech Transition

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com